Skip to content

Detection of Visual-Auditory Reaction Rates in Individuals With Type 2 Diabetes

Detection of Visual-Auditory Reaction Rates in Individuals With Type 2 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05725889
Enrollment
128
Registered
2023-02-13
Start date
2021-07-15
Completion date
2021-09-14
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Dysfunction, Diabetes Mellitus, Type 2, Nerve Damage

Brief summary

Background: The primary purpose of our study was to understand the damage in the peripheral nerves of patients with diabetes and to determine the change in patients' reaction rates and perceptions by the age groups, duration of diabetes, fasting plasma glucose and HbA1c values, and compare these with those of the healthy individuals. Methods: This study was carried out at the Baskent University Hospital Endocrinology and Metabolic Diseases Outpatient Clinic. A total of 64 patients diagnosed with type 2 diabetes and 64 healthy controls were included in the study. Finger tapping, visual, and auditory reaction time tests were performed on the subjects, respectively. The subjects' fasting plasma glucose and HbA1c levels, and the duration of their diabetes were recorded. Analyses were performed using the SPSS version 25. Differences were considered statistically significant when the p-value is \<0.05.

Interventions

DEVICErecation time test

visual-finger tapping and auditory reaction time tests

Sponsors

Baskent University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Right-handed individuals * Must be between 18-65 ages * Must be Type 2 diabetics at least 6 months (for patient group)

Exclusion criteria

* use of alcohol-drug or similar substances, * the use of any medication that may affect neurological functions, * having color blindness, * retinopathy, * neurological disease, * cancer, * depression, * a recent history of surgery, * rheumatoid arthritis, * osteoarthritis, * and advanced osteoarthritis.

Design outcomes

Primary

MeasureTime frameDescription
Finger tap, visual and auditory reaction test data within 10 secondsApril-September 2021Reaction times

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026